MENS (Jyong Biotech) Rega marang bathi mangsa ngarep

Simbol resmi perusahaan Jyong Biotech (MENS)

Jyong Biotech Ltd's efficient distribution of pharmaceutical substances, combined with the neutral status of plant-based dietary supplements, provides access to global markets. This chart of the company's forward P/E visualizes the dynamics of market expectations, where 0.00 shows the current value of the metric. However, global fragmentation and sanctions may hinder the conduct of international clinical trials, creating certain risks for business development.

jyongbio.com - Rasio kapitalisasi marang bathi mangsa ngarep MENS (periode 18.06.2025 - 16.11.2026)

Ringkesan rincian data analitis jyongbio.com (MENS)

Pambiji fundamental:MENS Jyong Biotech
Produk merek Jyong Biotech Ltd

The forward P/E ratio assesses the current share price relative to expected net income, allowing investors to determine the extent of the premium paid for future business growth. By analyzing the forward P/E trend for Jyong Biotech Ltd (MENS) on GURU.Markets, one can evaluate the degree to which the market currently prices in the company's success in sustainable plant-based production and adherence to strict bioethical standards.

Pesaing wigati

Rega marang bathi mangsa ngarep haleon.com (HLN)|KVUE (Kenvue Health) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Verona Pharma PLC VRNA|Ligand (LGND) - Rasio prakiraan rega marang bathi|AMRX: Prakiraan rega marang bathi|Perrigo - Rasio kapitalisasi marang bathi mangsa ngarep|ALVO: Pangali Forward P/E|Liquidia Technologies - Pangali mangsa ngarep rega marang bathi|GLPG (Galapagos N.V.) - Pangali Forward P/E|Rasio prakiraan rega marang bathi anipharmaceuticals.com ANIP|Rega marang bathi mangsa ngarep MannKind (MNKD)|AMPH (Amphastar Pharmaceuticals, Inc.) - Pangali mangsa ngarep rega marang bathi|Rega marang bathi mangsa ngarep Pacira BioSciences, Inc. PCRX|Pangali Forward P/E ARS Corp SPRY|Theravance Biopharma - Pangali Forward P/E|Pangali forward rega marang bathi Aquestive Therapeutics, Inc. (AQST)|scPharmaceuticals (SCPH) - Rega marang bathi mangsa ngarep|Prakiraan rega marang bathi Tectonic Therapeutic, Inc.|TNXP (Tonix Pharmaceuticals Holding) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep SXTC (China SXT Pharmaceuticals)|Pangali Forward P/E EPRX|Pangali Forward P/E bioharvest.com (BHST)|Rega marang bathi mangsa ngarep Invizyne Technologies EXOZ|ORMP: Rasio rega marang bathi mangsa ngarep|ENTX: Prakiraan rega marang bathi|HYFT: Rega marang bathi mangsa ngarep|ABVC BioPharma Inc. (ABVC) - Rega marang bathi mangsa ngarep|cumberlandpharma.com (CPIX) - Pangali Forward P/E|QNTM (Quantum BioPharma) - Pangali Forward P/E|FGEN: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E TELO|Pangali Forward P/E Rani Therapeutics Holdings (RANI)|Pangali Forward P/E SNYR (Synergy CHC Corp)|Rallybio Corporation (RLYB) - Rasio prakiraan rega marang bathi|LEXX - Rega marang bathi mangsa ngarep|PULM (Pulmatrix) - Rasio rega marang bathi mangsa ngarep|Pheton Holdings Ltd (PTHL) - Rega marang bathi mangsa ngarep|Aptorum - Pangali mangsa ngarep rega marang bathi|Prakiraan rega marang bathi LYRA|Prakiraan rega marang bathi Impact BioMedical Inc (IBO)|Pangali Forward P/E TNFA|YCBD: Rasio rega marang bathi sing dikarepake|Rega marang bathi mangsa ngarep PainReform PRFX|altamiratherapeutics.com (CYTO) - Rasio prakiraan rega marang bathi|LIPO: Prakiraan rega marang bathi|OPTN (optinose.com) - Rasio rega marang bathi mangsa ngarep|PIRS: Pangali Forward P/E|PROC - Kapitalisasi marang proyeksi bathi|PTPI (Petros Pharma) - Pangali Forward P/E|Rega marang bathi mangsa ngarep QLI|Pangali Forward P/E SLRN|Rasio kapitalisasi marang bathi mangsa ngarep TFFP